The FDA has approved the first prescription, at-home neuromodulation therapy for individuals with major depressive disorder ...

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under ...

At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.

The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment ...

Neurolief announced today that the FDA granted approval for its Proliv Rx at-home neuromodulation therapy for treating depression.

With its expansion into St. Louis, Restore Brain continues its mission to broaden access to advanced psychiatric treatments ...

For individuals with major depressive disorder (MDD) that does not respond to pharmacotherapy, recent decisions by the U.S.

SEOUL, South Korea--(BUSINESS WIRE)--Professor Kim Jae-ho of the Department of Neurology at Hallym University Dongtan Sacred Heart Hospital delivered a presentation titled “Transcranial Focused ...

At Stanford, a treatment that aims magnetic pulses at the brain is showing results for people with treatment-resistant depression. It’s called SAINT, and here’s how it works.

ProlivRx therapy scales physician-directed brain neuromodulation beyond the clinic into the homeCORAL SPRINGS, Fla., Jan. 12, 2026 /PRNewswire/ -- Neurolief Inc., a medical device company focused ...

First customer sites include the University of Arkansas for Medical Sciences, MUSC Health, and Calif.-based Acacia Clinics and Kaizen Brain Center BURLINGAME, Calif.--(BUSINESS WIRE)--Magnus Medical, ...

The International Neuromodulation Society (INS) journal Neuromodulation: Technology at the Neural Interface is publishing expert, evidence-based guidance on the safe and efficient use of ...